Pay in 4 interest-free payments of $5.49 Learn more
Ships within 48 hours · Estimated delivery Jul 27 - Aug 1
Consult a qualified healthcare provider before pursuing any peptide protocol
13-6800, Thermo Fisher Scientific), anti-SYNCRIP (R5653, Sigma-Aldrich), anti-SIRT1 (ab110304, Abcam, UK), anti-NRF2 (NBP1-32822, Novus, USA), anti-xCT (ab37185, Abcam), anti-GPX4 (ab125066, Abcam), anti-GFP (2956, Cell Signaling, USA), anti-Cleaved caspase 3 (9661, Cell Signaling), anti-PRDX3 (A304-744A, Bethyl Laboratories, USA), anti-PRDX5 (A305-339A, Bethyl Laboratories), anti-HK2 (ab209847, Abcam), and anti-ACTIN (A5316, Sigma- Aldrich, USA)
As of today, no completed, published, randomized controlled human trial exists for BPC-157 in any indication
Its proposed mechanisms, ranging from modulation of nitric oxide signaling to stabilization of neuromuscular junctions, suggest BPC-157 may significantly enhance recovery and functional outcomes in musculoskeletal injuries [20, 23, 25, 26, 43]
